IDXX · Business segments
IDEXX Laboratories (IDXX) revenue by segment
Where IDEXX Laboratories’s revenue comes from, as reported in its SEC filings.
Latest quarter: June 30, 2026
Total revenue on the income statement: $1.22B.
Revenue by Product
| Line | Revenue | Share |
|---|---|---|
| Product | $718.6M | 59.1% |
| Service | $498M | 40.9% |
Revenue by Segment
| Line | Revenue | Share |
|---|---|---|
| Companion Animal Group | $1.12B | 92.3% |
| Water | $58.6M | 4.8% |
| Livestock and Poultry Diagnostics | $35.2M | 2.9% |
Revenue by Geography
| Line | Revenue | Share |
|---|---|---|
| United States | $773M | 63.5% |
| EMEA | $265.5M | 21.8% |
| Asia Pacific | $101.5M | 8.3% |
| Canada | $50.8M | 4.2% |
| Latin American and Caribbean | $25.8M | 2.1% |
Latest year: December 31, 2025
Total revenue on the income statement: $4.3B.
Revenue by Product
| Line | Revenue | Share |
|---|---|---|
| Product | $2.54B | 59.0% |
| Service | $1.76B | 41.0% |
Revenue by Segment
| Line | Revenue | Share |
|---|---|---|
| Companion Animal Group | $3.95B | 92.2% |
| Water | $201.1M | 4.7% |
| Livestock and Poultry Diagnostics | $131.8M | 3.1% |
Reading notes
Share is each line’s part of that breakdown. Margin is the company’s reported segment operating income divided by that segment’s revenue. Companies define segment profit differently and may re-cut segments over time, so a company’s lines can differ between years. Breakdowns that do not add up to within 5% of reported revenue are left out.